Scientia in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Publications

Developing and Commercialising Companion Diagnostics
September 27, 2011
by Aruna Rajan, Michael Jacobson, Kerry Xie and Harry Glorikian, for European Medical Device Technology

---

Sequencing Trends Worth Watching - Commercial Potential of Technology Demands that Industry and Investors Alike Stay Up to Date
September 1st, 2011
by Harry Glorikian and Brian Clancy, for Genetic Engineering & Biotechnology News

---

Pricing and Reimbursement: Knowing Your Value up Front is Key to Future Dealmaking
June 14, 2011
by Patrick Terry for partneringNEWS

---

Demand Escalates for iPSC Life Science Tools - Induced Pluripotent Stem Cells Prove Invaluable in Toxicity and Drug Efficacy Screening
May 15, 2011
by Lisa Carey and Michael Tapella, for Genetic Engineering & Biotechnology News

---

Do Companion Dx Make Economic Sense? - Extensive Survey Identifies Four Different Scenarios and Just as Many Answers
April 15, 2011
by Amit Agarwal, for Genetic Engineering & Biotechnology News

---

Market access challenges in the EU for high medical value diagnostic tests
March 2011
co-authored by Patrick Terry, for Future Medicine

---

Data Sharing - Power to the People: Participant Ownership of Clinical Trial Data
February 9, 2011
by Patrick Terry, for Science Translational Medicine

---

Companion Diagnostics - A perfect storm
February 3, 2011
by Harry Glorikian, Kerry Xie and Jonathan Pan, for European Biotechnology News

---

Rethinking theranostics as a separate pharma category
January 12, 2011
by Amit Agarwal, for Medical Device Daily

---

POCT Key to Widespread Access to Healthcare
January 1, 2011
by Harry Glorikian, Aruna Rajan and Kerry Xie, for Medical Laboratory Observer

---

Regen Medicine Prepares for Growth Spurt - Novel Business Models, Emerging Players, and Transformative Products Starting to Have Impact
November 1, 2010
by Arshad Ahmed and Michael Tapella, for Genetic Engineering & Biotechnology News

---

Biomanufacturing Operations on Upswing - Biosimilars and Pharma's Growing Interest in Biologics Keep Manufacturing Plants Humming
October 1, 2010
by Amit Agarwal and Michael Omartian, for Genetic Engineering & Biotechnology News

---

Theranostics and Already Approved Drugs: What You Don't Know Can Hurt You
by Amit Agarwal and Jonathan Pan, for PAREXEL’s Bio/Pharmaceutical R&D Statistical Sourcebook 2010/2011

---

Treating T2DM with Early Insulin Therapy - Lack of Comprehensive Patient Education Has Stymied Adoption of Beneficial Treatment Option
by Amit Agarwal and John McNamara, for Genetic Engineering & Biotechnology News

---

NGS Market Remains on Upward Trajectory - Increased Gov't Funding Drives Expansion
By Brian Clancy and Harry Glorikian, for Genetic Engineering & Biotechnology News

---

Cell Biology Market Shows Resilience - Segment Encompasses a Plethora of Critical Tools from Petri Dishes to Robotics for HCS
by Johann Maradey, Lisa Carey and Harry Glorikian, for Genetic Engineering & Biotechnology News

---

Prepared Foods Exclusive: No Functional Fad
by Bob Jones, for Prepared Foods

---

Influenza Scare Not the Only Vaccine Driver - Novel Production Methods, Emerging Markets, and Improved Adjuvants Also Promoting Growth
by Harry Glorikian and Santosh Kuruvilla, for Genetic Engineering & Biotechnology News

---

Preparing for a Successful Launch
by Bob Jones for Natural Products Insider

---

The Underappreciated Cost-Saving Potential of Personalized Medicine in Health Reform Debate: The current draft includes comparative effectiveness research but does not provide nearly as much funding as is needed for CE
by Harry Glorikian and Brian Clancy, for Genetic Engineering & Biotechnology News

---

Tests to Rapidly Diagnose Sepsis Essential: Diagnostic That Can Quickly Detect Infection Could Speed Treatment and Improve Outcome
by Aruna Rajan and Harry Glorikian, for Genetic Engineering & Biotechnology News

---

The Emergence and Future of Companion Diagnostics: A 2009 Assessment
by Amit Agarwal and Aruna Rajan, for PAREXEL’s Bio/Pharmaceutical R&D